Clinical Trial

Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity

Name: Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity — clinical trial record (NCT07528027)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The main objective of this study is to demonstrate the superior efficacy of HRS-7535 in controlling blood pressure compared to placebo in subjects with hypertension and overweight or obesity;

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-06

Trial Details

NCT Number	NCT07528027
Lead Sponsor	Shandong Suncadia Medicine Co., Ltd.
Conditions	Hypertension With Overweight or Obesity
Enrollment	648 participants
Start Date	2026-05-29
Primary Completion	2027-12 (estimated)
Study Completion	2028-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-05